Brunei Darussalam vs Panama: Prevalence rate of diabetes in adults
Brunei Darussalam
9.4
in 2014
Panama
9.3
in 2014
Brunei Darussalam rank
76th
Panama rank
78th
Prevalence rate of diabetes in adults over time
- Brunei Darussalam
- Panama
How they compare
Brunei Darussalam currently reports 9.4 against 9.3 in Panama, a difference of 0.1.
Across all 35 years both countries report, Brunei Darussalam has been ahead every year.
Brunei Darussalam ranks 76th and Panama ranks 78th of 190 countries.
Brunei Darussalam has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Brunei Darussalam | Panama | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 7.69 | 5.25 | 2.44 | Brunei Darussalam |
| 1990s | 8.74 | 6.51 | 2.23 | Brunei Darussalam |
| 2000s | 9.51 | 7.9 | 1.61 | Brunei Darussalam |
| 2010s | 9.48 | 9 | 0.48 | Brunei Darussalam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of diabetes in adults, Brunei Darussalam or Panama?
- Brunei Darussalam, at 9.4 against 9.3 in Panama as of 2014.
- What is the difference in prevalence rate of diabetes in adults between Brunei Darussalam and Panama?
- 0.1, with Brunei Darussalam ahead.
- How many years of comparable data are there for Brunei Darussalam and Panama?
- 35 years are reported by both, from 1980 to 2014.
- How do Brunei Darussalam and Panama rank globally for prevalence rate of diabetes in adults?
- Brunei Darussalam ranks 76th and Panama ranks 78th of 190 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) β with minor processing by Our World in Data, published as Prevalence rate of diabetes in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of people with diabetes among those aged over 18, based on general population surveys and statistical modeling. Diabetes is a risk factor for chronic complications, including cardiovascular disease, and premature death.